Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study
By B. Williams, P. Lacy, H. Thurston, S. Thom, Alun D. Hughes, K. Cruickshank, A. Stanton, D. Collier, Michael F. O'Rourke. Circulation, 2006
2,402 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/e033c28bca02232f95836f7a3427ed97db949845
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- E. Schiffrin
- Philippe van de Borne
- I. Wilkinson
- J. Cockcroft
- S. Laurent
- Michael F. O'Rourke
- F. Cosentino
- H. S. Boudier
In Surgery
Citations in the corpus
- ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “Nonetheless, the possibility that ACCOMPLISH results may be due to a more effective reduction of central BP by the association of an RAS blocker with a calcium antagonist deserves to be investigated.(398,399,464)”
- The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “A slightly lower effectiveness of beta-blockers in preventing stroke [284] has been attributed to a lesser ability to reduce central SBP and pulse pressure [398,399].”
- Central blood pressure: current evidence and clinical importance. (2014, background): “Recent evidence suggests that central pressure is also more strongly related to future cardiovascular events 7 than brachial pressure, and responds differently to certain drugs.(8,9) Appreciating this provides an ideal framework for understanding the much publicized inferiority of atenolol and some ”
- The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. (2015, background): “Results are heterogeneous in studies on hypertensive patients [129] and in geriatric patients [130].”
- 2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007, background): “(166,167) Furthermore, the results obtained in a large substudy performed within a randomized trial have shown that central pulse pressure as assessed from the ‘augmentation index’ is significantly related to cardiovascular events.”
- 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “A slightly lower effectiveness of beta-blockers in preventing stroke [284] has been attributed to a lesser ability to reduce central SBP and pulse pressure [398,399].”
- Monitoring of the central blood pressure waveform via a conformal ultrasonic device (2018, neutral): “Those data, if carefully collected, can be critical for improving the efficacy of diagnosis and prognosis of cardiovascular diseases 43 .”
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, background): “These effects are advantageous from the viewpoint of the quality of blood pressure control, and are evaluated as characterizing CCBs [206, 725].”